healthcare News
Sangamo raises $25M at 17% discount, diluting shareholders 15.8%
Strategic funding provides working capital as clinical-stage biotech advances key pipeline programs toward regulatory submissions
Replimune surges 6% on earnings beat, financing relief
Hercules loan amendment extends cash runway to Q1 2027 as April PDUFA date for melanoma therapy confirmed
Merck cuts 2026 outlook by 43% on Gardasil plunge, margin squeeze
Pharmaceutical giant faces steep earnings decline as vaccine demand collapses in China and pandemic therapies fade
DaVita shares climb 1.7% on earnings beat, strong 2026 outlook
Dialysis provider projects 33% EPS growth and continues aggressive share buybacks
CorMedix authorizes $75M buyback after January stock plunge
Biopharmaceutical company launches repurchase program representing 12.3% of market cap, signaling confidence at depressed valuations
Revvity beats earnings forecasts, raises outlook on diagnostics strength
Healthcare technology company posts $772 million in fourth-quarter revenue and projects FY2026 EPS growth to $5.35-$5.45
AstraZeneca bets $18.5B on obesity drugs with China's CSPC
Pharmaceutical giant pays $1.2 billion upfront for once-monthly GLP-1 treatments in race to catch Novo Nordisk and Eli Lilly
Obesity drug shares face pressure as AstraZeneca enters market
AstraZeneca's $4.7B deal with China's CSPC targets once-monthly dosing to challenge LLY/NVO duopoly